Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Test-retest and inter-examiner reliability of a novel bedside quantitative sensory testing battery in postherpetic neuralgia patients.

Wasan AD, Alter BJ, Edwards RR, Argoff CE, Sehgal N, Walk D, Moeller-Bertram T, Wallace MS, Backonja M.

J Pain. 2019 Dec 11. pii: S1526-5900(19)30875-2. doi: 10.1016/j.jpain.2019.11.013. [Epub ahead of print]

PMID:
31837446
2.

ERK2 Alone Drives Inflammatory Pain But Cooperates with ERK1 in Sensory Neuron Survival.

O'Brien DE, Alter BJ, Satomoto M, Morgan CD, Davidson S, Vogt SK, Norman ME, Gereau GB, Demaro JA 3rd, Landreth GE, Golden JP, Gereau RW 4th.

J Neurosci. 2015 Jun 24;35(25):9491-507. doi: 10.1523/JNEUROSCI.4404-14.2015.

3.

Genetic targeting of ERK1 suggests a predominant role for ERK2 in murine pain models.

Alter BJ, Zhao C, Karim F, Landreth GE, Gereau RW 4th.

J Neurosci. 2010 Aug 25;30(34):11537-47. doi: 10.1523/JNEUROSCI.6103-09.2010.

4.

Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.

Thors L, Burston JJ, Alter BJ, McKinney MK, Cravatt BF, Ross RA, Pertwee RG, Gereau RW 4th, Wiley JL, Fowler CJ.

Br J Pharmacol. 2010 Jun;160(3):549-60. doi: 10.1111/j.1476-5381.2010.00716.x.

5.

Hotheaded: TRPV1 as mediator of hippocampal synaptic plasticity.

Alter BJ, Gereau RW 4th.

Neuron. 2008 Mar 13;57(5):629-31. doi: 10.1016/j.neuron.2008.02.023. Review.

6.
7.
8.

Murine APC activation in the xenogeneic MLC.

Benfield MR, Witson JC, Alter BJ, Bach FH.

Scand J Immunol. 1993 Aug;38(2):130-6.

PMID:
8346412
9.

Human anti-murine mixed leukocyte culture: effects of cytokines.

Benfield MR, Witson JC, Alter BJ, Bach FH.

Transplant Proc. 1991 Feb;23(1 Pt 1):219. No abstract available.

PMID:
1824977
10.

Factors in xenoantigen recognition.

Alter BJ, Bach FH.

Transplant Proc. 1990 Jun;22(3):1065. No abstract available.

PMID:
2349663
11.
12.

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.

Ochoa AC, Gromo G, Alter BJ, Sondel PM, Bach FH.

J Immunol. 1987 Apr 15;138(8):2728-33.

PMID:
2435804
13.

The stepwise activation of cytotoxic T lymphocytes.

Gromo G, Inverardi L, Geller RL, Alter BJ, Bach FH.

Immunol Today. 1987;8(9):259-61. doi: 10.1016/0167-5699(87)90183-6.

PMID:
25344279
14.

The growth of cells with LAK activity in an automated tissue culture system (Acusyst P).

Alter BJ, Ochoa AC, Gruenberg ML, Keyport GM, Bach FH.

Prog Clin Biol Res. 1987;244:301-11. No abstract available.

PMID:
3498955
15.

Long-term culture of LAK cells: expansion and activation signals.

Ochoa AC, Migliori RJ, Alter BJ, Sondel PM, Simmons RL, Bach FH.

Prog Clin Biol Res. 1987;244:289-99.

PMID:
3116557
16.

Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants.

Cairns JS, Curtsinger JM, Dahl CA, Freeman S, Alter BJ, Bach FH.

Nature. 1985 Sep 12-18;317(6033):166-8.

PMID:
3875800
17.

Histocompatibility and isoenzyme differences in commercially supplied "BALB/c" mice.

Kahan B, Auerbach R, Alter BJ, Bach FH.

Science. 1982 Jul 23;217(4557):379-81.

PMID:
6953593
19.

Allo-responsive T lymphocytes and their differentiation markers.

Bach FH, Alter BJ, Dunlap B, Koller B, Orosz C, Roehm N, Widmer MB.

Fed Proc. 1981 Apr;40(5):1466-70.

PMID:
6971234
20.

Cloned human T lymphocytes in PLT analysis of the HLA-D complex.

Inouye H, Hank J, Chardonnens X, Alter BJ, Reinsmoen NL, Segall M, Bach FH.

Transplant Proc. 1981 Mar;13(1 Pt 2):1030-2. No abstract available.

PMID:
6973852
21.

Lyt phenotypes of alloreactive precursor and effector cytotoxic T lymphocytes.

Roehm NW, Alter BJ, Bach FH.

J Immunol. 1981 Jan;126(1):353-8. No abstract available.

PMID:
6450238
22.

Cloned cytotoxic and non-cytotoxic lymphocytes in mouse and man: their reactivities and a large cell surface membrane protein (LMP) differentiation marker system.

Bach FH, Alter BJ, Widmer MB, Segall M, Dunlap B.

Immunol Rev. 1981;54:5-26. Review. No abstract available.

PMID:
6166537
23.

Cloned primed-lymphocyte-test reagents in the dissection of HLA-D.

Inouye H, Hank JA, Chardonnens X, Segall M, Alter BJ, Bach FH.

J Exp Med. 1980 Aug 1;152(2 Pt 2):143s-155s.

PMID:
6157764
24.

Antitumor cytotoxic T cells and non-T-cells generated by allosensitization in vitro.

Bach FH, Paciucci PA, Macphail S, Sondel PM, Alter BJ, Zarling JM.

Transplant Proc. 1980 Mar;12(1):2-7. No abstract available.

PMID:
6445107
25.

Long-term maintenance of "cloned" human PLT cells in TCGF with LCL cells as a feeder layer.

Hank JA, Inouye H, Guy LA, Alter BJ, Bach FH.

J Supramol Struct. 1980;13(4):525-32.

PMID:
6971962
26.

TCGF production for cloning and growth of functional human T lymphocytes.

Inouye H, Hank JA, Alter BJ, Bach FH.

Scand J Immunol. 1980;12(2):149-54.

PMID:
6255556
27.

Retention of specific proliferative capacity of cloned human T cells alloactivated against HLA-D alleles.

Pawelec G, Rehbein A, Alter BJ, Wernet P.

Immunogenetics. 1980;11(5):527-32. No abstract available.

PMID:
6242887
28.

T lymphocyte subpopulations responsive to alloantigens.

Bach FH, Alter BJ, Sopori ML.

J Reticuloendothel Soc. 1979 Dec;26(Suppl):587-96. Review. No abstract available.

PMID:
392085
29.

Lyt phenotypes of responding cells in secondary alloantigen responses.

Alter BJ, Bach FH.

J Immunol. 1979 Dec;123(6):2599-601.

PMID:
159321
30.

Human T lymphocytes clones reactive in primed lymphocyte typing and cytotoxicity.

Bach FH, Inouye H, Hank JA, Alter BJ.

Nature. 1979 Sep 27;281(5729):307-9. No abstract available.

PMID:
162150
31.

Past, present, and future aspects of histocompatibility.

Bach FH, Gose JE, Alter BJ, Sondel PM, Bach ML.

Transplant Proc. 1979 Mar;11(1):1207-11.

PMID:
377618
32.

Specultations on alternative pathways of T-lymphocyte response.

Alter BJ, Bach FH.

Scand J Immunol. 1979;10(2):87-93. No abstract available.

PMID:
91192
33.

Alternative pathways of T lymphocyte activation.

Bach FH, Alter BJ.

J Exp Med. 1978 Sep 1;148(3):829-34.

34.
35.

Cell-free factor substitute for "signal 2" in generating cytotoxic reactions.

Sopori ML, Alter BJ, Bach FH, Bach ML.

Eur J Immunol. 1977 Nov;7(11):823-5. No abstract available.

PMID:
73468
36.

Antigenic requirements for the generation of secondary cytotoxicity.

Grillot-Courvalin C, Alter BJ, Bach FH.

J Immunol. 1977 Oct;119(4):1253-9.

PMID:
142790
37.

Primed lymphocyte typing in the assay of HLA-D region disparity.

Bach ML, Jarrett-Toth E, Benike C, Shih CY, Valentine E, Alter BJ, Bach FH.

Transplant Proc. 1977 Mar;9(1):405-9. Review. No abstract available.

PMID:
141130
38.

Cellular immunogenetics and LD-CD collaboration.

Bach FH, Kuperman OJ, Sollinger HW, Zarling JM, Sondel PM, Alter BJ, Bach ML.

Transplant Proc. 1977 Mar;9(1):859-63. Review. No abstract available.

PMID:
68606
39.

Antigenic requirements for triggering of cytotoxic T lymphocytes.

Bach FH, Grillot-Courvalin C, Kuperman OJ, Sollinger HW, Hayes C, Sondel PM, Alter BJ, Bach ML.

Immunol Rev. 1977;35:76-96. Review. No abstract available.

PMID:
142746
40.

Typing an unrelated panel with PLT cells: association with DW clusters.

Alter BJ, Bach FH, Jaramillo S, Wernet P.

Scand J Immunol. 1977;6(5):458-7.

PMID:
70063
41.

Specific detection of HLA-D antigens using primed LD typing (PLT).

Sondel PM, Sheehy MJ, Benike C, Alter BJ, Bach FH.

Transplant Proc. 1976 Sep;8(3):449-53. No abstract available.

PMID:
62435
42.

Typing for HLA-D: primed LD typing and homozygous typing cells.

Bach FH, Valentine EA, Alter BJ, Svejgaard A, Thomsen M.

Tissue Antigens. 1976 Aug;8(2):151-5. No abstract available.

PMID:
135377
43.

Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors.

Alter BJ, Grillot-Courvalin C, Bach ML, Zier KS, Sondel PM, Bach FH.

J Exp Med. 1976 May 1;143(5):1005-14.

44.
45.

Genetic and cellular control of in vitro models of allograft reactivity.

Bach FH, Alter BJ, Schendel DJ, Segall M, Bach ML.

Birth Defects Orig Artic Ser. 1975;11(1):467-76.

PMID:
238687
47.

The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment.

Schendel DJ, Alter BJ, Bach FH.

Transplant Proc. 1973 Dec;5(4):1651-5. No abstract available.

PMID:
4272823
48.

Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped families.

Mawas C, Sasportes M, Christen Y, Bernard A, Dausset J, Alter BJ, Bach ML.

Transplant Proc. 1973 Dec;5(4):1683-9. No abstract available.

PMID:
4130077
49.

Cell-mediated lympholysis. Importance of serologically defined H-2 regions.

Alter BJ, Schendel DJ, Bach ML, Bach FH, Klein J, Stimpfling JH.

J Exp Med. 1973 May 1;137(5):1303-9.

50.

Cell mediated immunity: separation of cells involved in recognitive and destructive phases.

Bach FH, Segall M, Zier KS, Sondel PM, Alter BJ, Bach ML.

Science. 1973 Apr 27;180(4084):403-6.

PMID:
4267047

Supplemental Content

Loading ...
Support Center